Skip to content

BIO-SCALE Act

In committee: it can still change before the session ends.

US HR 8918 · House Bill · 119th Congress

Draft a letter
Stage
In committee
Started in
House
Sponsors
2
Latest action
May 20, 2026

What it does

The BIO-SCALE Act would establish at least three regional, nonprofit, open-access technology maturation facilities to support the bioindustrial sector by advancing the development, testing, and scaling of bio-based technologies for commercialization. These facilities would be operated by eligible entities such as public and private foundations, nonprofit organizations, and institutions of higher education incorporated and primarily operating in the United States, with funding authorized at $345 million for FY2026–2028 and $117 million for FY2029–2030. The Secretary of Commerce would oversee the competitive selection of facilities, prioritize geographic distribution and proximity to…

No official summary is available here. This one was written by AI from the bill’s text.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    May 20, 2026

  2. Committee (Current step)

    In committee · May 20, 2026

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

BIO-SCALE Act | 52